Results 91 to 100 of about 105,883 (220)

Serum Concentration Relationships of Candesartan in Migraine Prevention

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT Migraine is a common disabling disorder, and optimising affordable preventive treatments remains highly relevant. Candesartan is an effective and well‐tolerated preventive treatment, but little is known about its dose‐concentration–response relationships.
Hedda Skogum Riise   +13 more
wiley   +1 more source

Characterization of patients with medically unexplained intolerance to enteral feeding treated with home parenteral nutrition: A descriptive cohort study

open access: yesJournal of Parenteral and Enteral Nutrition, Volume 50, Issue 7, Page 1024-1030, October 2026.
Abstract Background and Aims Dutch intestinal failure centers are increasingly confronted with patients started on total parenteral nutrition because of reported intolerance to enteral feeding without meeting clinical criteria for intestinal failure.
J. W. Korzilius   +11 more
wiley   +1 more source

How are managed headache sufferers outside from specialized centres? A pharmaco-epidemiology report

open access: yes, 2002
Headache patients employs more often OTCs (41.83%) than patients followed by the headache centre (16.45%). Only 14% of patients observed for the first time made a prophilactic treatment. Headache patients not followed by specialised care centre are often
FERRARI, Anna   +2 more
core  

Australian Guideline for the Identification and Management of Hypertension in Children and Adolescents

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
N. G. Larkins   +28 more
wiley   +1 more source

A Team‐Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Real‐World Dosing Patterns and Persistence Among Patients With and Without a History of Methamphetamine Use

open access: yesPulmonary Circulation, Volume 16, Issue 4, October 2026.
ABSTRACT Selexipag is an oral prostacyclin receptor agonist approved for pulmonary arterial hypertension (PAH). This single‐center, retrospective study described oral selexipag dosing patterns and persistence, overall and stratified by history of methamphetamine (meth) use, at an expert center in California, USA, using a multidisciplinary, nurse ...
Samuel B. Brusca   +13 more
wiley   +1 more source

Spontaneous Intracranial Hypotension Treated with a Targeted CT-Guided Epidural Blood Patch

open access: yesCase Reports in Medicine, 2016
Spontaneous intracranial hypotension (SIH) is an important cause of new daily persistent headache. It is thought to be due to spontaneous spinal cerebrospinal fluid (CSF) leaks, which probably have a multifactorial etiology.
Inês Correia   +4 more
doaj   +1 more source

Low‐Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double‐Blind, Double‐Dummy Controlled Trial

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 10, October 2026.
ABSTRACT Background Androgenetic alopecia (AGA) is a prevalent, progressive condition with significant psychosocial impact. Current pharmacological modalities like topical minoxidil and finasteride have limitations. Low‐dose oral minoxidil has surfaced as a valid off‐label solution, with the practical advantage of once‐daily dosing.
Muhammad Asad Ejaz Chaudhry   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy